Jim Cramer Backs Ingredion as a Powerhouse After Tate & Lyle Deal
Jim Cramer is bullish on Ingredion following its Tate & Lyle acquisition, calling it a future ingredient powerhouse.
Jim Cramer is putting his stamp of approval on Ingredion (INGR), and the thesis is straightforward: the Tate & Lyle deal transforms this company into something much bigger than it was before. When Cramer talks up a name, traders pay attention — whether they love him or hate him, the man moves retail sentiment.
The Tate & Lyle acquisition is the core of the story here. Ingredion was already a solid specialty ingredients player, but folding in Tate & Lyle's business gives the combined entity serious scale, broader product lines, and a stronger foothold in the global food and beverage supply chain. That's not a small upgrade — that's a structural step-change.
Read more BoE's Mann: Fewer Rate Hike Bets Are Why She'd Hike More →
For traders, the question is whether the market has fully priced in the upside from this deal or whether Cramer is flagging an opportunity before the Street catches up. Specialty ingredients companies tend to fly under the radar until they don't — and a Cramer endorsement is the kind of catalyst that puts a ticker on more watchlists overnight.
The food ingredient space itself is worth watching. Consumer staples have been a mixed bag, but companies with pricing power and diversified input exposure tend to hold up better when macro conditions get choppy. If Ingredion can execute on integration, the combined operation could deliver the kind of steady earnings growth that long-term investors and income-focused traders both want to see.
Bottom line: Cramer sees a powerhouse in the making. Whether you trade the momentum or dig into the fundamentals, INGR just got a lot more interesting. Continue reading at Yahoo Finance.
